PEOPLE - Changes at UroGen (US):
This article was originally published in Clinica
Executive Summary
US company UroGen has named Dr Robert Sobol president and chief executive officer. Dr Sobol, a founder of IDEC Pharmaceuticals, had previously been executive vice-president and chief operating officer of UroGen. He replaces Paul Quadros who becomes chairman. Dr Sobol also joins the board of directors, together with Victor Schmitt and Dr Wei-Wei Zhang, both from Baxter Healthcare. Following a partnering agreement with Baxter, Urogen has expanded its product line to include diagnostics and treatment for cancer and genetic disorders as well as prostate cancer.